Disclosure Of Entity's Operating Segments [Text Block]

Isofol Medical - Filing #701189

Concept	As at 2021-12-31	2021-01-01 to 2021-12-31	2021-01-01 to 2021-12-31	2020-01-01 to 2020-12-31	As at 2020-12-31	2020-01-01 to 2020-12-31
Disclosure of entity's operating segments [text block]	—	—	—	—	—	—
Disclosure of operating segments [text block]	—	—	—	—	—	—
Disclosure of operating segments [abstract]
Disclosure of operating segments [line items]
Revenue	—	22 407 SEK	—	—	—	37 119 SEK
Depreciation and amortisation expense	—	1 596 SEK	—	—	—	1 770 SEK
Tax expense (income)	—	– SEK	—	—	—	1,000 SEK
Profit (loss) before tax	—	20 0 251 SEK	—	—	—	188 991 SEK
Profit (loss)	—	20 0 251 SEK	200 251 SEK	188 992 SEK	—	188 992 SEK
Assets	401 363 SEK	—	—	—	148 130 SEK	—
Liabilities	83 130 SEK	—	—	—	81 563 SEK	—
Cash flows from (used in) operating activities	—	188 429 SEK	—	—	—	160 270 SEK
Cash flows from (used in) investing activities	—	- SEK	—	—	—	- SEK
Cash flows from (used in) financing activities	—	450 47 7 SEK	—	—	—	150 013 SEK
Disclosure of products and services [text block]	—	—	—	—	—	—
Disclosure of products and services [abstract]
Disclosure of products and services [line items]
Disclosure of geographical areas [text block]	—	—	—	—	—	—
Disclosure of geographical areas [abstract]
Disclosure of geographical areas [line items]
Disclosure of major customers [text block]	—	—	—	—	—	—
Disclosure of major customers [abstract]
Disclosure of major customers [line items]